• 1
    Compton W. M., Thomas Y. F., Stinson F. S., Grant B. F. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007; 64: 566576.
  • 2
    Farrell M., Howes S., Bebbington P., Brugha T., Jenkins R., Lewis G. et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry 2001; 179: 432437.
  • 3
    Teesson M., Hall W. D., Lynskey M., Degenhardt L. Alcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2000; 34: 206213.
  • 4
    Ghitza U. E., Gore-Langton R. E., Lindblad R., Shide D., Subramaniam G., Tai B. Common data elements for substance use disorders in electronic health records: the NIDA Clinical Trials Network experience. Addiction 2013; 108: 38.
  • 5
    Teesson M., Clements N., Copeland J., Conroy A., Reid A. 2000) Measuring outcome in drug and alcohol treatment settings. NDARC Technical Report No. 92.
  • 6
    Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev 2005; 24: 143155.
  • 7
    Proudfoot H., Teesson M. Who gets treatment for alcohol use disorders in Australia? Findings from the Australian National survey of mental health and wellbeing. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 451456.
  • 8
    Harris M. G., Burgess P. M., Pirkis J. E., Slade T. N., Whiteford H. A. National policy initiative to improve access to psychological services for people with affective and anxiety disorders: a population-level analysis. Br J Psychiatry 2011; 198: 99108.